Therefore, we analysed data derived from the International Cancer Genome Consortium (ICGC) [40] and found that KMT2C truncation mutations (nonsense and frameshift mutations) correlate with reduced disease-free survival (DFS) in PCa (Fig. 6f). The gene discussed is KMT2C; the disease is posterior cortical atrophy.